The Hyderabad-based drugmaker plans to start late-stage, or stage-3,
trials of Covaxin next month with over 26,000 volunteers, who will be
monitored for drug efficacy. Approval for this came from the Indian
drug controller last week.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bharat-biotech-hopes-to-file-for-covaxin-approvals-by-next-june/articleshow/78862788.cms
No comments:
Post a Comment